Cargando…

Enhancement of in vitro antitumour activity of epirubicin in HER2+ breast cancer cells using immunoliposome formulation

Epirubicin (EPI) is one of the potent breast cancer (BC) chemotherapeutic agents, but its adverse effects limit its efficacy. Herein, EPI was selected to be loaded in liposomal carrier, which has been targeted by a monoclonal antibody, Herceptin. The preparation process of liposomes was a modified e...

Descripción completa

Detalles Bibliográficos
Autores principales: Khaleseh, Farnaz, Hemmati Azandaryani, Abbas, Fathian Kolahkaj, Fatemeh, Khazaei, Mozafar, Derakhshandeh, Katayoun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675807/
https://www.ncbi.nlm.nih.gov/pubmed/34694666
http://dx.doi.org/10.1049/nbt2.12012